The Future of Cancer Screening

When it comes to surviving cancer, the single most important factor is catching it early. Once
cancer spreads to distant organs (Stage 4), survival rates drop drastically—yet catching it even
one stage earlier can cause survival rates to skyrocket. In this video, we explore The Future of
Cancer Screening, why traditional screening methods are failing us, and how a newly FDA-
approved blood test could completely change the game.

For decades, standard population-based cancer screenings like mammograms, colonoscopies,
PSA tests, and CT scans have been considered the cornerstone of cancer prevention. However, a landmark 2023 study in JAMA Internal Medicine revealed a shocking truth: most conventional screening tests fail to show any statistically significant increase in overall lifespan. Why?

Because traditional tests are based on an outdated paradigm that looks for tumor size rather than tumor spread (metastasis).

Today, breakthrough technology allows us to detect minute levels of circulating tumor DNA
(ctDNA) through a simple, non-invasive blood test—often called a liquid biopsy. We dive deep into the Galleri Test by GRAIL, a Multi-Cancer Early Detection (MCED) test evaluated in a massive 140,000-patient randomized controlled trial. Discover how shifting detection from Stage 4 to Stage 3 can improve survival rates by 4x to 6x in lethal cancers like bladder, liver, bile duct, and esophageal cancer—cancers that previously had no early screening tests at all.

In this video, you will learn:
● Cancer Stages Explained: The critical difference between early-stage disease (Stage 1 &
2), regional spread (Stage 3), and distant metastasis (Stage 4).
● The Truth About Current Screenings: Insights from the 2023 JAMA study on
mammograms, colonoscopies, PSA tests, and the risks of unnecessary invasive biopsies.
● Tumor Size vs. Metastasis: Why the genetic paradigm of cancer is outdated and why early
spread matters far more than tumor size.
● What is a Liquid Biopsy (ctDNA)? How Multi-Cancer Early Detection (MCED) blood tests
identify cancer signatures across dozens of cancer types simultaneously.
● The Galleri Test Clinical Trial: Breaking down the 140,000-patient trial results and how
annual testing reduces Stage 4 cancer diagnoses by up to 26%.
● Stage 3 vs. Stage 4 Survival Rates: How catching bladder, liver, and esophageal cancers
just one stage earlier increases survival by 4x to 6x.
� Subscribe to the channel for more science-backed health insights:

�� Recommended Reading: To learn more about the evolutionary paradigm of cancer, wh
traditional models fall short, and how we can better prevent and treat disease, check out the book:
The Cancer Code.

�� Get the book –
Disease/dp/0062894013
ABOUT DR. JASON FUNG
Dr. Jason Fung is a physician and bestselling author known for his work and educational content on
fasting, nutrition, insulin, and metabolic health.
Subscribe for more educational videos on fasting, nutrition, obesity, and metabolic health.
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
⏱️ Video Chapters (Timestamps):
00:00 – The Future of Cancer Screening & Why Early Detection Matters
00:42 – The 4 Stages of Cancer & Metastasis Explained
01:24 – The Problem with Traditional Cancer Screenings (Mammograms, PSA & Colonoscopy)
02:15 – Why Over 70% of Cancer Deaths Aren't Prevented by Current Screenings
03:30 – 2023 JAMA Study: Do Mammograms & Colonoscopies Actually Save Lives?
05:30 – Life Gained from Traditional Screenings: The Shocking Data
06:21 – Why Current Tests Fail: Tumor Size vs. Early Metastasis (The Cancer Code)
08:08 – What is Circulating Tumor DNA (ctDNA) & Liquid Biopsy?
08:37 – The Galleri Test by GRAIL: Multi-Cancer Early Detection (MCED)
09:34 – 140,000-Patient Trial Results: Stage 4 vs. Stage 3 Cancer Reduction
12:08 – Stage 3 vs. Stage 4 Survival Rates (Bladder, Liver & Esophageal Cancer)
14:07 – FDA Approval & Why Liquid Biopsies Are the Future of Cancer Screening
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
�� Please visit our :-
�� Website –
�� Blog-
�� Community-
�� Facebook –

�� Instagram –
�� Twitter –
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
If you liked the video, Please Do Subscribe My Channel ����
Keep Supporting me So I can Continue to provide you with free content each week!!��
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
�� �� Thank you for Watching
#TheFutureOfCancerScreening #CancerScreening #LiquidBiopsy #GalleriTest
#EarlyCancerDetection #TheCancerCode #ctDNA #CancerPrevention #MedicalBreakthrough
#DrJasonFung

Cameron Long

Cameron is a seasoned CFO and CPA with 31 years in finance. He created the AI Trader's Playbook to help everyday investors use AI to find high-confidence trades — in minutes, not hours.

Read More About Cameron →    Get the AI Trader's Playbook